Cargando…
Interrogating the CD27:CD70 axis in αCD40-dependent control of pancreatic adenocarcinoma
Immune checkpoint blockade immunotherapy has radically changed patient outcomes in multiple cancer types. Pancreatic cancer is one of the notable exceptions, being protected from immunotherapy by a variety of mechanisms, including the presence of a dense stroma and immunosuppressive myeloid cells. P...
Autores principales: | Gamache, Awndre, Conarroe, Claire, Adair, Sara, Bauer, Todd, Padilla, Frederic, Bullock, Timothy N. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130518/ https://www.ncbi.nlm.nih.gov/pubmed/37123403 http://dx.doi.org/10.3389/fcell.2023.1173686 |
Ejemplares similares
-
The CD70-CD27 axis in oncology: the new kids on the block
por: Flieswasser, Tal, et al.
Publicado: (2022) -
The price of the CD27–CD70 costimulatory axis: you can't have it all
por: Nolte, Martijn A., et al.
Publicado: (2006) -
Ecto-5′-Nucleotidase (CD73) Regulates the Survival of CD8+ T Cells
por: Rosemblatt, Mariana V., et al.
Publicado: (2021) -
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling
por: Li, Song, et al.
Publicado: (2023) -
Multimeric forms of CD40 ligand (CD40L), 4-1BB ligand (4-1BBL), OX40 ligand (OX40L), CD27L/CD70, and other TNFSFs as tools for adoptive cell therapy
por: Kornbluth, Richard S
Publicado: (2013)